Clasiete, Kim Caitlin C. BSN 3-2 Px. A.F Female, 26 y/o Dx.

: Chronic Calcular Cholecytitis, post Cholecystectomy CC: 1 mon. PTA, px. Experienced sharp pain on right upper abdominal quadrant, with nausea and vomitting DRUG MECHANISM OF ACTION INDICATION/ SIDE EFFECT/ CONTRAINDICATION Generic: Ranitidine Brand name: None Classification: Anti-ulcer agents Dosage: 50 mg Frequency: Every 8 hrs Route: IV Color: none Form: IV Injection Inhibits the action of histamine at the H2 receptor site located primarily in gastric parietal cells, resulting in inhibition of gastric acid secretion.In addition, ranitidine bismuth citrate has some antibacterial action against H. pylori. I: Treatment and prevention of heartburn, acid indigestion, and sour stomach C: Hypersensitivity, Crosssensitivity may occur; some oral liquids contain alcohol and should be avoided in patients with known intolerance. ADVERSE EFFECT CNS: Confusion, dizziness, drowsiness, hallucinations, headache CV: Arrhythmias GI: Altered taste, black tongue, constipation, dark stools, diarrhea, drug-induced hepatitis, nausea GU: Decreased sperm count, impotence ENDO: Gynecomastia HEMAT: Agranulocytosis, Aplastic Anemia, neutropenia, thrombocytopenia LOCAL: Pain at IM site MISC: Hypersensitivity reactions, vasculitis

NURSING RESPONSIBILITY

Assess patient for epigastric or abdominal pain and frank or occult blood in the stool, emesis, or gastric aspirate. Nurse should know that it may cause false-positive results for urine protein; test with sulfosalicylic acid. Inform patient that it may cause drowsiness or dizziness. Inform patient that increased fluid and fiber intake may minimize constipation. Advise patient to report onset of black, tarry stools; fever, sore throat; diarrhea; dizziness; rash; confusion; or hallucinations to health care professional promptly. Inform patient that medication may temporarily cause stools and tongue to appear gray black.